Sign inJoin waitlistJoin the waitlist

Christopher Dvorak

Division Chief of Allergy, Immunology, & Bone Marrow Transplantation · University of California (San Francisco) School of Medicine

Credentials: · ·

History

Immunology Division · University of California (San Francisco) School of Medicine
Present
Division of Allergy, Immunology, and Bone Marrow Transplantation · University of California (San Francisco) School of Medicine
Present
University of California (San Francisco) School of Medicine
Present

Pediatric Hematology Oncology
Lucile Salter Packard Children's Hospital at Stanford
2001–2004
Stanford University Medical Center-GME
1998–2001
Vanderbilt University School of Medicine
1994–1998
Vanderbilt University
1990–1994

Research

Transplantation outcomes for severe combined immunodeficiency, 2000-2009
New England Journal of Medicine · 2014 · 540 citations
Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors
Case report · Cancer Research · 1999 · 459 citations
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis
The Lancet Haematology · 2016 · 247 citations

Morton Cowan
79 papers
Michael Pulsipher
56 papers
Jennifer Puck
45 papers
Sung-Yun Pai
40 papers
Luigi Notarangelo
35 papers
Donald Kohn
32 papers
LG
Linda Griffith
32 papers
NK
Neena Kapoor
32 papers
Matt Zinter
27 papers · 9 as a resident
Jennifer Heimall
26 papers · 9 as a resident
Sandhya Kharbanda
24 papers
Blachy Saldaña
23 papers

Grants

Primary Immune Deficiency Treatment Consortium (PIDTC): A Resource to Drive Scientific and Clinical Advances Related to the Treatment of Inborn Errors of Immunity
National Institute of Allergy and Infectious Diseases · R24
Contact PI · $5.3M · University of California, San Francisco
2024–2029
Primary Immune Deficiency Treatment Consortium
National Institute of Allergy and Infectious Diseases · U54
PI · $7.8M · University of California, San Francisco
2009–2025

Clinical trials

Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation
Principal investigator · Completed · Phase 2
University of California, San Francisco
2015–2019
Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
Principal investigator · Terminated · Phase 2
University of California, San Francisco
2012–2019
Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim
Principal investigator · Terminated · Phase 2
University of California, San Francisco
2010–2013
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
Principal investigator · No longer available
Christopher Dvorak